Journal article
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
-
Copelan, Edward A.
Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC;
-
Hamilton, Betty K.
Cleveland Clinic Foundation, Cleveland, OH;
-
Avalos, Belinda
Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC;
-
Ahn, Kwang Woo
Center for International Blood and Marrow Transplant Research, Milwaukee, WI;
-
Bolwell, Brian J.
Cleveland Clinic Foundation, Cleveland, OH;
-
Zhu, Xiaochun
Center for International Blood and Marrow Transplant Research, Milwaukee, WI;
-
Aljurf, Mahmoud
King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia;
-
van Besien, Koen
Weill Cornell Medical College, New York, NY;
-
Bredeson, Christopher
Division of Hematology, Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada;
-
Cahn, Jean-Yves
Department of Hematology, University Hospital, Grenoble, France;
-
Costa, Luciano J.
Medical University of South Carolina, Charleston, SC;
-
de Lima, Marcos
University Hospitals Case Medical Center, Cleveland, OH;
-
Gale, Robert Peter
Imperial College, Section of Hematology, Division of Experimental Medicine, Department of Medicine, London, United Kingdom;
-
Hale, Gregory A.
All Children’s Hospital, St. Petersburg, FL;
-
Halter, Joerg
University Hospital Basel, Basel, Switzerland;
-
Hamadani, Mehdi
West Virginia University Hospitals, Morgantown, WV;
-
Inamoto, Yoshihiro
Fred Hutchinson Cancer Research Center, Seattle, WA;
-
Kamble, Rammurti T.
Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX;
-
Litzow, Mark R.
Mayo Clinic Rochester, Rochester, MN;
-
Loren, Alison W.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
-
Marks, David I.
Bristol Children’s Hospital, Bristol, United Kingdom;
-
Olavarria, Eduardo
Catherine Lewis Center, Pamplona, Spain;
-
Roy, Vivek
Mayo Clinic, Jacksonville, FL;
-
Sabloff, Mitchell
Division of Hematology, Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada;
-
Savani, Bipin N.
Vanderbilt University Medical Center, Brentwood, TN;
-
Seftel, Matthew
Cancer Care Manitoba/University of Manitoba, Winnipeg, Manitoba, Canada;
-
Schouten, Harry C.
Academische Ziekenhuis Maastricht, Maastricht, The Netherlands;
-
Ustun, Celalettin
University of Minnesota Medical Center, Fairview, Minneapolis, MN;
-
Waller, Edmund K.
Emory University Hospital, Atlanta, GA;
-
Weisdorf, Daniel J.
University of Minnesota Medical Center, Fairview, Minneapolis, MN;
-
Wirk, Baldeep
Shands HealthCare and University of Florida, Gainesville, FL;
-
Horowitz, Mary M.
Center for International Blood and Marrow Transplant Research, Milwaukee, WI;
-
Arora, Mukta
University of Minnesota Medical Center, Fairview, Minneapolis, MN;
-
Szer, Jeff
Royal Melbourne Hospital City Campus, Victoria, Australia;
-
Cortes, Jorge
MD Anderson Cancer Center, Houston, TX; and
-
Kalaycio, Matt E.
Cleveland Clinic Foundation, Cleveland, OH;
-
Maziarz, Richard T.
Oregon Health and Science University, Portland, OR
-
Saber, Wael
Center for International Blood and Marrow Transplant Research, Milwaukee, WI;
Show more…
Published in:
- Blood. - American Society of Hematology. - 2013, vol. 122, no. 24, p. 3863-3870
English
Key Points
In combination with cyclophosphamide, intravenous busulfan is associated with better leukemia-free and overall survival in AML than TBI.
-
Language
-
-
Open access status
-
green
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/81486
Statistics
Document views: 46
File downloads: